IP Library Granted Patent US 11,654,112
Granted Patent B2
US 11,654,112 · App. 16/463,238 · Granted May 23, 2023

Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof

Inventors: Chase Coffman (Boston, MA); Lyndon Charles (Medford, MA); Paul Brown (Boston, MA); Daniel Benjamin Dadon (Cambridge, MA); Lisa Liu (Somerville, MA); Cory Robinson (Cambridge, MA)
Assignee: Elektrofi, Inc.
A61K9/1682A61K9/5089A61K39/395B05B5/025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,654,112
App. No.
16/463,238
Granted
May 23, 2023
Kind
B2
Abstract

The invention provides particles, compositions including the particles, and methods of making the particles using electrospray. In certain embodiments, the particles allow for high concentrations of a therapeutic or diagnostic agent to be delivered at low viscosity. Particles may also exhibit beneficial properties with respect to stability.

Claims (11)

1. A method of electrospraying an aqueous first liquid comprising aa protein and (ii) a carbohydrate, a salt, or a combination thereof to form droplets and evaporating the aqueous first liquid to produce particles from the droplets, wherein the carbohydrate, salt, or the combination thereof is observed at the surface of the particles in large quantities; and

wherein the protein in the particles has 0.5 to 1.0 activity per unit.

2. The method of claim 1 , wherein the concentration of the protein in the aqueous first liquid is from 0.0001 to 1000 mg/mL.

3. The method of claim 1 , wherein the aqueous first liquid is selected from the group consisting of water, 0.9% saline, lactated Ringer's solution, dextrose 5%, and a buffer.

4. The method of claim 1 , wherein the carbohydrate is dextran, trehalose, sucrose, agarose, mannitol, lactose, sorbitol, or maltose.

5. The method of claim 1 , wherein the salt is sodium chloride, calcium chloride, potassium chloride, sodium hydroxide, stannous chloride, magnesium sulfate, sodium glucoheptonate, sodium pertechnetate, or guanidine hydrochloride.

6. The method of claim 1 , wherein the particles have diameters from 0.1 to 1000 μm.

7. The method of claim 1 , wherein the particles have a polydispersity index from 0.05 to 0.9.

8. The method of claim 1 , wherein the protein is an antibody.

9. The method of claim 8 , wherein the antibody is human IgG or a monoclonal antibody.

10. The method of claim 1 , wherein the protein is bovine serum albumin (BSA).

Assignments (2)
CHANGE OF NAME Recorded Feb 2, 2026
From: ELEKTROFI, INC.
To: HALOZYME HYPERCON, INC.
Reel/Frame 073662/0717 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2023
From: COFFMAN, CHASE; CHARLES, LYNDON FITZGERALD, JR.; BROWN, PAUL; DADON, DANIEL BENJAMIN; LIU, LISA; ROBINSON, CORY
To: ELEKTROFI, INC.
Reel/Frame 065281/0427 →
Continuity (6)
Provisional Application 62476190 · Mar 24, 2017
Provisional Application 62476173 · Mar 24, 2017
Provisional Application 62468735 · Mar 8, 2017
Provisional Application 62468727 · Mar 8, 2017
Provisional Application 62425399 · Nov 22, 2016
Related Publication 20190374470A1 · Dec 12, 2019
Cited By (7)
US 12,263,249 US 12,263,253 US 12,377,050 US 12,433,849 US 12,558,323 US 12,569,445 US 12,600,763